Philips has landed a ten-year $100 million telehealth contract with the U.S. Department of Veterans Affairs (VA), the company announced in a statement Wednesday.
This contract enables VA to invest up to $100 million with Philips for the creation of the world’s largest telehealth system.
Philips has also formed a strategic collaboration with BioIntelliSense to integrate its BioSticker™ medical device into Philips’ remote patient monitoring (RPM) to monitor at-risk patients from the hospital into the home.
Royal Philips, a leading health technology company, announced that the U.S. Department of Veterans Affairs (VA) has awarded them a contract to expand VA’s Tele-Critical Care technology and services. This 10-year $100 million contract will enable the creation of the world’s largest system to provide veterans remote access to intensive care expertise, regardless of their location.
In recent years, the U.S. Department of Veterans Affairs has began investing in telehealth systems to better support the 9 million veterans nationwide it serves annually. The remote capabilities that these systems provide have proven their value and importance during the coronavirus pandemic. Between February and May, the number of remote video appointments performed by the U.S. Department of Veterans Affairs increased 12x, from 10k appointments per week to 120k per week. Furthermore, in 2019 alone, the VA performed more than 2.5 million telehealth episodes.
The U.S. Department of Veterans Affairs is the largest integrated healthcare system in the U.S. and manages 1,800 ICU beds nationwide. The “eICU” is not only meant to give patients access to specialists, but will also optimize care costs, enhance clinician and patient satisfaction and improve outcomes. Philips’ VitalWatch eICU program, which was put into practice by four Health First hospitals, resulted in:
- 23% reduction in overall mortality across the four hospitals as a whole
- 49% reduction in ICU length of stay
- 35% reduction in lengths of stay throughout the four hospitals
BioIntelliSense, a continuous health monitoring and clinical intelligence company, has formed a strategic collaboration to enhance remote patient monitoring for at-risk patients remotely. This collaboration is will allow the integration of BioIntelliSense’s BioSticker™ into Philips’ remote patient monitoring systems. Multi-parameter sensors used in the BioSticker monitor multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms.
As COVID-19 continues its spread, healthcare systems are continuing to seek solutions to protect workers and patients. At AegisPPE, we have been working diligently to supply medical facilities with facemasks, respirators, gowns, gloves, hand sanitizer, and eye protection (i.e., face shields or goggles).